Injury-induced MRP8/MRP14 stimulates IP-10/CXCL10 in monocytes/macrophages

Juan Wang1, Yoram Vodovotz2, Liyan Fan3

  • 1State Key Laboratory of Organ Failure Research, Key Laboratory of Transcriptomics and Proteomics, Ministry of Education of China, Key Laboratory of Proteomics of Guangdong Province, Southern Medical University, Guangzhou, China; Department of Surgery, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA;

Insights

Damage-associated molecular pattern MRP8/MRP14 is lower in trauma non-survivors. This study reveals MRP8/MRP14 signaling via Toll-like receptor 4 and TRIF drives IP-10 production, impacting inflammation.

Area of Science:

  • Immunology
  • Molecular Biology
  • Trauma Research

Background:

  • Trauma and hemorrhagic shock induce inflammation, increasing morbidity and mortality.
  • Monocytes/macrophages, stimulated by damage-associated molecular patterns (DAMPs), drive this inflammation.
  • The DAMP MRP8/MRP14's role in trauma-induced inflammation requires clarification.

Purpose of the Study:

  • To elucidate the signaling mechanisms by which MRP8/MRP14 stimulates IP-10 production in monocytes/macrophages.
  • To investigate the role of MRP8/MRP14 and IP-10 in trauma/hemorrhagic shock outcomes.

Main Methods:

  • Measured circulating MRP8/MRP14 and IP-10 levels in human blunt trauma patients.
  • Stimulated human monocytic THP-1 cells with MRP8/MRP14 to assess IP-10 expression.
  • Investigated signaling pathways (TLR4, TRIF, MyD88, NF-κB, IRF3) involved in MRP8/MRP14-induced IP-10 production.
  • Assessed MRP8/MRP14-induced chemotaxis of CXCR3(+) cells.
  • Utilized a mouse trauma/hemorrhagic shock model with anti-MRP8 antibody treatment.

Main Results:

  • Lower circulating MRP8/MRP14 and IP-10 levels were observed in trauma non-survivors compared to survivors.
  • MRP8/MRP14 stimulation of THP-1 cells induced IP-10 expression.
  • IP-10 induction required Toll-like receptor 4 (TLR4) and TRIF, synergizing NF-κB and IRF3 transcription factors.
  • MRP8/MRP14-induced chemotaxis of CXCR3(+) cells depended on monocyte-derived IP-10.
  • In vivo, anti-MRP8 antibody administration reduced NF-κB/IRF3 activation and IP-10 production in a mouse model.

Conclusions:

  • Identified a novel signaling pathway where MRP8/MRP14 activates TLR4/TRIF, leading to NF-κB and IRF3-dependent IP-10 production in monocytes/macrophages.
  • This MRP8/MRP14-IP-10 axis plays a significant role in regulating inflammation following trauma/hemorrhagic shock.
  • Targeting MRP8/MRP14 may offer a therapeutic strategy for mitigating injury-induced inflammation.